Barchart.com
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Dorchester Minerals (DMLP)

Dorchester Minerals (DMLP)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
30.37 +0.08 (+0.26%) 04/02/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 30.37 unch (unch) 16:00 ET
Quote Overview for Wed, Apr 2nd, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Day Low
30.09
Day High
30.44
Open 30.10
Previous Close 30.29 30.29
Volume 38,600 38,600
Avg Vol 83,365 83,365
Stochastic %K 71.01% 71.01%
Weighted Alpha -11.82 -11.82
5-Day Change +0.48 (+1.61%) +0.48 (+1.61%)
52-Week Range 28.25 - 35.74 28.25 - 35.74
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
 Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,433,929
  • Shares Outstanding, K 47,340
  • Annual Sales, $ 161,520 K
  • Annual Income, $ 89,200 K
  • EBIT $ 135 M
  • EBITDA $ 178 M
  • 60-Month Beta 0.79
  • Price/Sales 8.82
  • Price/Cash Flow 10.79
  • Price/Book 3.94

Options Overview Details

View History
  • Implied Volatility 28.25% ( +1.31%)
  • Historical Volatility 20.62%
  • IV Percentile 21%
  • IV Rank 41.60%
  • IV High 52.57% on 11/01/24
  • IV Low 10.93% on 06/17/24
  • Put/Call Vol Ratio 0.27
  • Today's Volume 42
  • Volume Avg (30-Day) 70
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 2,138
  • Open Int (30-Day) 1,994
Free Barchart Webinars! Live educational sessions using site features to explore today's markets.
Get delivered to your inbox for FREE:
Sign Up.

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.25 +7.50%
on 03/03/25
Period Open: 30.41
30.51 -0.46%
on 03/20/25
-0.04 (-0.13%)
since 02/28/25
3-Month
28.25 +7.50%
on 03/03/25
Period Open: 34.68
34.88 -12.93%
on 01/03/25
-4.31 (-12.43%)
since 01/02/25
52-Week
28.25 +7.50%
on 03/03/25
Period Open: 35.13
35.74 -15.03%
on 04/03/24
-4.76 (-13.55%)
since 04/02/24

Most Recent Stories

More News
Dorchester Minerals, L.P. Announces 2024 Results GlobeNewswire - Thu Feb 20, 4:22PM CST

DMLP : 30.37 (+0.26%)
Dorchester Minerals, L.P. Announces Its Fourth Quarter Distribution GlobeNewswire - Thu Jan 23, 3:10PM CST

DMLP : 30.37 (+0.26%)
Insider Purchase: Chief Financial Officer of $DMLP (DMLP) Buys 12,050 Shares Quiver Quantitative, Inc. - Fri Dec 6, 2024

LESLIE A MORIYAMA, the Chief Financial Officer of $DMLP ($DMLP), bought 12,050 shares of the company on 12-03-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This...

DMLP : 30.37 (+0.26%)
Insider Purchase: Chief Executive Officer of $DMLP (DMLP) Buys 14,430 Shares Quiver Quantitative, Inc. - Fri Dec 6, 2024

BRADLEY J EHRMAN, the Chief Executive Officer of $DMLP ($DMLP), bought 14,430 shares of the company on 12-03-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This...

DMLP : 30.37 (+0.26%)
Dorchester Minerals, L.P. Announces Third Quarter Results GlobeNewswire - Thu Oct 31, 2024

DMLP : 30.37 (+0.26%)
Dorchester Minerals, L.P. Announces Its Third Quarter Distribution GlobeNewswire - Thu Oct 17, 2024

DMLP : 30.37 (+0.26%)
Dorchester Minerals, L.P. Announces Appointment of Manager to Board of Managers GlobeNewswire - Tue Oct 15, 2024

DMLP : 30.37 (+0.26%)
Dorchester Minerals, L.P. Announces Second Quarter Results Globe Newswire - Thu Aug 4, 2022

DALLAS, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announced today the Partnership’s net income for...

DMLP : 30.37 (+0.26%)
Dorchester Minerals, L.P. Announces Its Second Quarter Distribution Globe Newswire - Thu Jul 21, 2022

DALLAS, TEXAS , July 21, 2022 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (NASDAQ:DMLP) announced today the Partnership’s second quarter 2022 cash...

DMLP : 30.37 (+0.26%)
Dorchester Minerals, L.P. Announces First Quarter Results Globe Newswire - Thu May 5, 2022

DALLAS, May 05, 2022 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announced today the Partnership’s net income for the...

DMLP : 30.37 (+0.26%)
Artelo Biosciences to Present at the LD Micro Invitational XII on June 7th Globe Newswire - Wed Jun 1, 2022

SOLANA BEACH, Calif., June 01, 2022 (GLOBE NEWSWIRE) --  Artelo Biosciences, Inc. “Artelo” or the “Company”) (NASDAQ: ARTL), a clinical-stage...

ARTL : 0.8800 (+2.31%)
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 ACCESS Newswire - Mon May 16, 2022

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies...

RCAT : 7.42 (+16.12%)
FBIO : 1.6100 (+4.55%)
AGRI : 1.2800 (+6.67%)
MODD : 1.0400 (-3.70%)
SMFL : 0.0026 (unch)
IONM : 0.0001 (-99.00%)
AWH : 0.1100 (+14.58%)
SACH : 1.1100 (-4.31%)
EDT.TO : 0.77 (unch)
ISDR : 9.65 (+2.12%)
MG : 10.39 (-0.95%)
LPTH : 2.0100 (+3.08%)
Artelo Biosciences to Present at the H.C. Wainwright Global Investment Conference on May 24th Globe Newswire - Mon May 16, 2022

SOLANA BEACH, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. “Artelo” or the “Company”) (NASDAQ: ARTL), a clinical stage...

ARTL : 0.8800 (+2.31%)
Artelo Biosciences to Present at MicroCap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 16th ACCESS Newswire - Fri May 13, 2022

SOLANA BEACH, CA / ACCESSWIRE / May 13, 2022 / Artelo Biosciences, Inc. "Artelo" or the "Company") (NASDAQ:ARTL), a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling...

ARTL : 0.8800 (+2.31%)
Artelo Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update Globe Newswire - Thu May 12, 2022

$23.5 Million in Cash and Investments as of March 31, 2022, Expected to Support Completion of the CAReS Trial and Operations Into Second Half of 2023 ...

ARTL : 0.8800 (+2.31%)
Artelo Biosciences Reports Positive Pre-clinical Results for Lead Program in Cancer-Related Cachexia Globe Newswire - Wed Apr 13, 2022

New Research from Trinity College Dublin Indicates Broader Therapeutic Potential for ART27.13...

ARTL : 0.8800 (+2.31%)
Artelo Expands Collaboration with Trinity College Dublin to Investigate Cellular Biology of Fatty Acid Binding Protein (FABP) Inhibition In Cancer Globe Newswire - Mon Mar 28, 2022

New Potential Uses of ART26.12 for Treating Tumors...

ARTL : 0.8800 (+2.31%)
Artelo Biosciences to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th Globe Newswire - Tue Mar 22, 2022

SOLANA BEACH, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical stage pharmaceutical company developing...

ARTL : 0.8800 (+2.31%)
Artelo Biosciences Reports Four-Month 2021 Financial Results in Connection with its Amended Fiscal Year End and Provides Business Update Globe Newswire - Mon Mar 21, 2022

Reports $25.6 Million in Cash and Marketable Securities as of December 31, 2021, Expected to Support Operations Into Second Half of 2023...

ARTL : 0.8800 (+2.31%)
Artelo Biosciences Receives Notice of Allowance for Method-of-Use Patent in the United States for ART12.11, a Proprietary Cocrystal of Cannabidiol Globe Newswire - Wed Mar 2, 2022

SOLANA BEACH, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on...

ARTL : 0.8800 (+2.31%)
Artelo Biosciences to Present at the LD Micro Invitational XII on June 7th Globe Newswire - Wed Jun 1, 2022

SOLANA BEACH, Calif., June 01, 2022 (GLOBE NEWSWIRE) --  Artelo Biosciences, Inc. “Artelo” or the “Company”) (NASDAQ: ARTL), a clinical-stage...

ARTL : 0.8800 (+2.31%)
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 ACCESS Newswire - Mon May 16, 2022

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies...

RCAT : 7.42 (+16.12%)
FBIO : 1.6100 (+4.55%)
AGRI : 1.2800 (+6.67%)
MODD : 1.0400 (-3.70%)
SMFL : 0.0026 (unch)
IONM : 0.0001 (-99.00%)
AWH : 0.1100 (+14.58%)
SACH : 1.1100 (-4.31%)
EDT.TO : 0.77 (unch)
ISDR : 9.65 (+2.12%)
MG : 10.39 (-0.95%)
LPTH : 2.0100 (+3.08%)
Artelo Biosciences to Present at the H.C. Wainwright Global Investment Conference on May 24th Globe Newswire - Mon May 16, 2022

SOLANA BEACH, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. “Artelo” or the “Company”) (NASDAQ: ARTL), a clinical stage...

ARTL : 0.8800 (+2.31%)
Artelo Biosciences to Present at MicroCap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 16th ACCESS Newswire - Fri May 13, 2022

SOLANA BEACH, CA / ACCESSWIRE / May 13, 2022 / Artelo Biosciences, Inc. "Artelo" or the "Company") (NASDAQ:ARTL), a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling...

ARTL : 0.8800 (+2.31%)
Artelo Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update Globe Newswire - Thu May 12, 2022

$23.5 Million in Cash and Investments as of March 31, 2022, Expected to Support Completion of the CAReS Trial and Operations Into Second Half of 2023 ...

ARTL : 0.8800 (+2.31%)
Artelo Biosciences Reports Positive Pre-clinical Results for Lead Program in Cancer-Related Cachexia Globe Newswire - Wed Apr 13, 2022

New Research from Trinity College Dublin Indicates Broader Therapeutic Potential for ART27.13...

ARTL : 0.8800 (+2.31%)
Artelo Expands Collaboration with Trinity College Dublin to Investigate Cellular Biology of Fatty Acid Binding Protein (FABP) Inhibition In Cancer Globe Newswire - Mon Mar 28, 2022

New Potential Uses of ART26.12 for Treating Tumors...

ARTL : 0.8800 (+2.31%)
Artelo Biosciences to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th Globe Newswire - Tue Mar 22, 2022

SOLANA BEACH, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical stage pharmaceutical company developing...

ARTL : 0.8800 (+2.31%)
Artelo Biosciences Reports Four-Month 2021 Financial Results in Connection with its Amended Fiscal Year End and Provides Business Update Globe Newswire - Mon Mar 21, 2022

Reports $25.6 Million in Cash and Marketable Securities as of December 31, 2021, Expected to Support Operations Into Second Half of 2023...

ARTL : 0.8800 (+2.31%)
Artelo Biosciences Receives Notice of Allowance for Method-of-Use Patent in the United States for ART12.11, a Proprietary Cocrystal of Cannabidiol Globe Newswire - Wed Mar 2, 2022

SOLANA BEACH, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on...

ARTL : 0.8800 (+2.31%)
More news for this symbol

Barchart Technical Opinion

Strong sell

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Dorchester Minerals, L.P. engages in the acquisition, ownership, and administration of producing and nonproducing natural gas and crude oil royalty, net profits, and leasehold interests in the United States. The Company owns two categories of properties: the Net Profits Interests and the Royalty Properties,...

See More

DMLP Related ETFs

Managed Assets
Percent
Symbol %Holdings 3M %Chg
DMLP -12.43%
Dorchester Minerals
INFL 0.49% +7.08%
Horizon Kinetics Inflation Beneficiaries ETF
MDIV 1.14% +1.17%
Multiasset Diversified Income Index Fund FT
CVY 1.26% +0.99%
Zacks Multi-Asset Income Invesco ETF
NDIV 3.86% +3.80%
Amplify Natural Resources Dividend Income ETF
Symbol %Holdings 3M %Chg
DMLP -12.43%
Dorchester Minerals
NDIV 3.86% +3.80%
Amplify Natural Resources Dividend Income ETF
CVY 1.26% +0.99%
Zacks Multi-Asset Income Invesco ETF
INFL 0.49% +7.08%
Horizon Kinetics Inflation Beneficiaries ETF
MDIV 1.14% +1.17%
Multiasset Diversified Income Index Fund FT

DMLP Related stocks

Symbol Last 3M %Chg
DMLP 30.37 -12.43%
Dorchester Minerals
STR 20.27 +2.27%
Sitio Royalties Corp
KRP 14.31 -12.80%
Kimbell Royalty Partners
SBR 68.12 +4.54%
Sabine Royalty Trust
PBT 10.25 -11.18%
Permian Basin Royalty Trust
SJT 5.47 +31.49%
San Juan Basin Royalty Trust

Compare Symbols

Key Turning Points

Daily
52-Week
3rd Resistance Point 30.86
2nd Resistance Point 30.65
1st Resistance Point 30.51
Last Price 30.37
1st Support Level 30.16
2nd Support Level 29.95
3rd Support Level 29.81

See More

52-Week High 35.74
Fibonacci 61.8% 32.88
Fibonacci 50% 32.00
Fibonacci 38.2% 31.11
Last Price 30.37
52-Week Low 28.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades
Wed, Apr 09, 2025 5:00 PM UTC
Reserve Your Spot

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.

Start 30-Day Risk Free Trial